Elicio Therapeutics, Inc. Finance Lease, Liability, Undiscounted Excess Amount
Elicio Therapeutics, Inc. (ELTX) had Finance Lease, Liability, Undiscounted Excess Amount of $1.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2022-08-15
- 2022-06-30: Finance Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2022-03-31: Finance Lease, Liability, Undiscounted Excess Amount $11.00K.
- 2021-12-31: Finance Lease, Liability, Undiscounted Excess Amount $20.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-06-30 | $1.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $11.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $20.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |